Atlas Trials

Neoadjuvant Toripalimab Plus Docetaxel and Carboplatin in Patients With Localized TNBC (NeoTOP)

Clinical trial NCT06618014 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06618014
Sponsor
Sun Yat-sen University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerTriple Negative Breast Cancer
Start date
2022-01-11
Primary completion
2024-12-31
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.